GlassScriptPrepare for your visit
Daniel Hoover
Optometrist · Littleton, CO · NPI 1386959104
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$12,372.56
in general payments reported to CMS, 2019-2025 · $3,552 in 2025
The $3,552 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Who reported paying
General payments only, top 6 by amount.
- Johnson & Johnson Vision Care, INC. $8,336.97
- Alcon Vision LLC $2,359.53
- Coopervision INC. $554.10
- Bausch & Lomb Americas INC. $364.36
- Glaukos Corporation $297.40
- Bausch & Lomb, A Division of Bausch Health US, LLC $184.31
Drugs and devices associated with these payments
Acuvue Myday Contact Lens Infuse Total30 Precision 1 Precision7 Rxsight Injector Handpiece Rxsight Light Delivery Device (Ldd) Light Adjustable Lens (Lal) Rxsight Injector Cartridge Rxsight Contact Lens Izervay
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Daniel Hoover listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1086151/daniel-hoover